Dr. Reddy’s acquiring Mayne Pharma’s U.S. generic portfolio for $90 million
Representational image only.
| Photo Credit: Special Arrangement
Pharma major Dr. Reddy’s Laboratories is acquiring the U.S. generic prescription product portfolio of Australia’s Mayne Pharma Group for an upfront cash consideration of…